Rapid Diagnostek
Key advantages
60 Second, quantitative immunoassay results
One step, no reagents
Tests for a range of analytes
Not laboratory dependent
Produces electronically
transmittable data
Uses disposable sensors
HomeAbout UsProductPressContact
Rapid Diagnostek, Inc. Announces Platform Technology Agreement

LOVELAND, CO, May 4, 2011—Rapid Diagnostek, Inc. and Heska Corporation
(NASDAQ:HSKA; "Heska"), a leading provider of advanced diagnostic and specialty products to veterinarians, today announced the addition of new platform technology for the growth of its advanced diagnostic product line. The Companies announced a research, development and commercial agreement in the field of companion animal diagnostics. Full story

 
 
  Rapid Diagnostek Inc.has developed a patented, inexpensive, easy to use sensor appropriate for detecting bacteria, viruses, spores and disease biomarkers. Markets of opportunity include human and veterinary diagnostic, environmental, biohazard, bioterrorism, agricultural commodity, and food safety testing. Our technology offers remarkably faster and less expensive results than existing methods. Current diagnostic tests can take hours to days from the time a sample is taken to delivery of results. Rapid Diagnostek’s IntelliProbe Immunosensor™ (IPI™) platform can deliver results at the point of sampling in under 60 seconds. The sensor has performed as intended in the laboratory and the company is now developing a fully functioning device and initial assays to aggressively move towards commercialization.